Famotidine Powder, For Suspension
Product Images NDC 64980-737

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Famotidine (NDC 64980-737). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure.jpg (Chemical Structure)

Chemical structure of Famotidine showing its molecular bonds and arrangement of atoms, including sulfur, nitrogen, carbon, and hydrogen.*

FDA Label Image

Container-label.jpg (Container Label)

Label for Famotidine oral suspension, USP, 40 mg/5 mL powder for suspension, containing 400 mg famotidine per 50 mL after reconstitution. The label indicates the product is for oral use only, with instructions to shake well before each use. It is distributed by Rising Pharma Holdings, Inc., East Brunswick, NJ, with an NDC of 64980-737-50. Directions for reconstitution and storage are also included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.